INTRODUCTION
Iron deficiency anaemia remains the commonest medical disorder in pregnancy in developing countries with the burden of diseases impacting on both mother and the newborn. 1 In severe iron deficiency oral iron therapy although found to be an effective way of supplementation of iron but has its limitations such as it does not stimulate erythropoiesis quickly, requires to be continued for a longer duration of time, has many side effects and poor patient compliance. 2 Parenteral iron has shown to be an effective therapy to supply enough iron for erythropoiesis in cases of severe iron deficiency anaemia and thereby reducing the need of blood transfusion.
Intravenous iron sucrose gives rapid and safe reversal of iron deficiency anaemia. In a government hospital setting it is helpful to reduce maternal morbidity and mortality arising due to iron deficiency anaemia. 3 This prospective observational study was conducted to assess the efficiency of intravenous iron sucrose in the treatment of iron deficiency anaemia in antenatal patients, to study its side effects and as a pilot study for recommendation as a departmental policy in future for treatment of iron deficiency in pregnancy.
METHODS
This study was carried out on 30 antenatal patients of iron deficiency anaemia in a government medical college hospital after permission from the institutional ethical committee. The amount of iron sucrose was calculated and administered daily inj. Iron sucrose 100mg in 100 ml normal saline over 30 minutes, continuous monitoring and keeping emergency drug cart ready. Patients were evaluated after 4 weeks by Hb and peripheral smear for cell morphology.
RESULTS
The data were compiled and statistical analysis done using student's t test.
As shown in Table 1 mean age group of females is in the reproductive age i.e. 25.46±3.51. Even females from urban region are found to have anaemia which is a cause of concern. Further recurring pregnancies in multipara makes them depleted of iron stores due to increased demand and deficient supply.
Side effects reported were not severe and treated symptomatically ( Table 2 ).
The mean rise in Hb levels after four weeks ranged from 2.28 to 3.75 in moderate and severe anaemia (Table 3) .
Statistically significant change in haemoglobin levels as depicted in Table 4 establishes the efficacy of iron sucrose therapy. 
DISCUSSION
In this study mean age of patients is 25±3 yrs, 63% anaemic mothers were multiparae which is an important etiological factor. 33% females were severely anaemic and 66% had moderate anaemia.
The efficacies of iron sucrose therapy in both groups were compared and results show that there is satisfactory rise in haemoglobin levels in both groups.
The rise in Hb gm% ranged from 2-3 gm% increase from baseline up to 6 gm% in three patients.
The mean rise in Hb levels with inj. Iron sucrose is 2.887 (95% CI, p value <0.001) which is statistically significant and thus establish its efficacy in treatment.
In this study minor side effects as shown in Table 2 were reported and treated symptomatically. No serious side effect such as anaphylaxis was reported.
Thus the safety and efficacy of inj. Iron sucrose is well established in our study as reported by other authors. [4] [5] [6] 
